CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Pfizer partners with Enodia Therapeutics in $500m drug deal

PartnershipSec61 inhibitorsPositive
AI Analysis

Summary

Pfizer and Enodia Therapeutics announced a research collaboration and licensing agreement potentially worth over $500 million to discover and develop Sec61 inhibitors.

Importance:7/10
Sentiment:
0.60
partnershiplicensingdrug discoverySec61 inhibitors
Related Companies

Read the original article

Published by Pharmaceutical Technology on October 14, 2026 7:40 AM

Read Original